Phase I evaluation of cediranib, a selective VEGFR signalling inhibitor, in combination with gefitinib in patients with advanced tumours-Reference-Cited by-同舟云学术

Phase I evaluation of cediranib, a selective VEGFR signalling inhibitor, in combination with gefitinib in patients with advanced tumours

Published:2010-03 Issue:5 Volume:46 Page:901-911
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

van Cruijsen Hester,Voest Emile E.,Punt Cornelis J.A.,Hoekman Klaas,Witteveen Petronella O.,Meijerink Martijn R.,Puchalski Thomas A.,Robertson Jane,Saunders Owain,Jürgensmeier Juliane M.,van Herpen Carla M.L.,Giaccone Giuseppe

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference42 articles.

1. Vascular endothelial growth factor: basic science and clinical progress;Ferrara;Endocr Rev,2004

2. Epidermal growth factor-related peptides and their receptors in human malignancies;Salomon;Crit Rev Oncol Hematol,1995

3. Epidermal growth factor receptor and HER2-neu mRNA expression in non-small cell lung cancer is correlated with survival;Brabender;Clin Cancer Res,2001

4. Epidermal growth factor receptor and angiogenesis: opportunities for combined anticancer strategies;van Cruijsen;Int J Cancer,2005

5. The hallmarks of cancer;Hanahan;Cell,2000

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cediranib ameliorates portal hypertensive syndrome via inhibition of VEGFR-2 signaling in cirrhotic rats;European Journal of Pharmacology;2024-02

2. Tyrosine kinase inhibitors in osteosarcoma: Adapting treatment strategiesa;Journal of Bone Oncology;2023-12

3. The roles of glycolysis in osteosarcoma;Frontiers in Pharmacology;2022-08-17

4. Phase I study of cediranib, an oral VEGFR inhibitor, in combination with selumetinib, an oral MEK inhibitor, in patients with advanced solid malignancies;Investigational New Drugs;2021-09-13

5. CRISPR-mediated ablation of overexpressed EGFR in combination with sunitinib significantly suppresses renal cell carcinoma proliferation;PLOS ONE;2020-05-15